Atherothrombosis: plaque instability and thrombogenesis

Prog Cardiovasc Dis. 2002 Mar-Apr;44(5):381-94. doi: 10.1053/pcad.2002.123469.

Abstract

Hemostasis involves a carefully regulated balance between circulating and endothelium-derived prothrombotic and antithrombotic factors. The unstable or vulnerable plaque facilitates thrombosis, clinically manifest as an acute coronary syndrome (ACS), by creating an environment that favors thrombus formation over prevention of lysis. Endothelial cell dysfunction is integral to both the development of the atherosclerotic lesion as well as its destabilization. The transformation of a stable plaque to an unstable one involves complex interactions among T lymphocytes, macrophages, endothelial cells, and smooth muscle cells. Degradation of the fibrous cap of the atherosclerotic lesion as well as the overexpression of prothrombotic and underexpression of antithrombotic factors by cells within the plaque precede thrombus formation. Accordingly, pharmacological interventions for the treatment of ACS are directed against the initiation and propagation of thrombosis, as well as toward improvement of endothelial function.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Coronary Artery Disease* / drug therapy
  • Coronary Artery Disease* / etiology
  • Coronary Artery Disease* / pathology
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / etiology*
  • Endothelium, Vascular* / drug effects
  • Endothelium, Vascular* / pathology
  • Endothelium, Vascular* / physiology
  • Hemostasis / physiology
  • Humans
  • Membrane Proteins / metabolism
  • Rupture, Spontaneous / etiology

Substances

  • Membrane Proteins